illicit americas - united nations office on drugs and crime · · 2016-06-15illicit manufacture...

Illicit Man

ufacture

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Afric

a

Southe

rn Africa

Coun

try or Territory

Year

Main substances

Number of Laboratories*

Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial

Labs with additional

substances

Additio

nal sub

stances

Labs with main substances only

Breakd

own according to add

ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

South Africa

82013

Methaqu

alon

e8

HONLAF

11Hy

drop

onic

11HO

NLAF

1GHB

1HO

NLAF

7Methcathino

ne7

HONLAF

27To

tal lab

oratories specified

by substance, Sou

th Africa‐2013:

Western and

Cen

tral Africa

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

Nigeria

42012

Methamph

etam

ine (non

‐spe

cifie

d)1

11

14

4AR

Q

4To

tal lab

oratories s

pecifie

d by

sub

stan

ce, N

igeria‐2012:

Nigeria

12011

Unkno

wn

11

Methamph

etam

ine (non

‐spe

cifie

d)1

ARQ

1To

tal lab

oratories s

pecifie

d by

sub

stan

ce, N

igeria‐2011:

Americas

Central A

merica

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

El Salvado

r1

2013

Cocaine (non

‐spe

cifie

d)1

11

11

0AR

Q

1To

tal lab

oratories specified

by substance, El Salvado

r‐2013

:

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Guatemala

42014

Methamph

etam

ine (non

‐spe

cifie

d)4

0AR

Q

5Am

phetam

ine (non

‐spe

cifie

d)5

0AR

Q

9To

tal lab

oratories specified

by substance, Gua

temala‐2014:

Guatemala

42013

Amph

etam

ine (non

‐spe

cifie

d)4

0AR

Q

4Methamph

etam

ine (non

‐spe

cifie

d)4

0AR

Q

8To

tal lab

oratories specified

by substance, Gua

temala‐2013:

Northern Am

erica

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

Canada

72014

Cann

abis oil

50

11

50

00

07

ARQ

3MDA

20

10

00

20

2Ke

tamine, M

ethamph

etam

ine (non

‐spe

cifie

d)1

ARQ

1Dimethyltryptamine (DMT)

10

00

01

00

01

ARQ

4MDM

A2

02

00

11

01

Methamph

etam

ine (non

‐spe

cifie

d)3

ARQ

29Methamph

etam

ine (non

‐spe

cifie

d)4

718

00

31

03

Ephe

drine

26AR

Q

1Ephe

drine

10

00

01

00

01

ARQ

2Alprazolam

02

00

00

20

02

ARQ

3GHB

20

10

02

00

03

ARQ

50To

tal lab

oratories specified

by substance, Can

ada‐2014:

Canada

22013

LSD

10

01

00

10

2AR

Q

13Methamph

etam

ine (non

‐spe

cifie

d)6

07

00

06

06

7AR

Q

1Synthe

tic drugs

11

1AR

Q


11

1AR

Q

2MDM

A1

12

ARQ

1Ke

tamine

1AR

Q

1Mushroo

ms

11

1AR

Q

4Cann

abis oil

31

34

ARQ

25To

tal lab

oratories specified

by substance, Can

ada‐2013:

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Canada

32012

Cann

abis oil

21

11

3AR

Q

19Methamph

etam

ine (non

‐spe

cifie

d)13

33

85

19AR

Q

4GHB

22

11

4AR

Q

5MDM

A3

11

21

1MDP

2P4

ARQ


21

2AR

Q

1JW

H‐01

81

11

ARQ

1Fentanyl

11

1AR

Q

1MDA

11

11

ARQ

36To

tal lab

oratories specified

by substance, Can

ada‐2012:

Canada

352011

Methamph

etam

ine (non

‐spe

cifie

d)19

214

520

82

Phen

cyclidine (PCP

)33

ARQ

1Methcathino

ne1

11

ARQ


11

1AR

Q

2Fentanyl

21

12

PMA

0AR

Q

1Unkno

wn

11

1AR

Q

4GHB

31

4AR

Q

4MDM

A4

31

4AR

Q

48To

tal lab

oratories specified

by substance, Can

ada‐2011:

Mexico

102014

Heroin

1010

ARQ

131

Methamph

etam

ine (non

‐spe

cifie

d)13

113

1AR

Q

9Morph

ine

99

9AR

Q

150

Total lab

oratories s

pecifie

d by

sub

stan

ce, M

exico‐2014:

Mexico

32013

Non

‐spe

cifie

d3

3AR

Q

122

Methamph

etam

ine (non

‐spe

cifie

d)12

212

2AR

Q

3He

roin

33

ARQ

128

Total lab

oratories s

pecifie

d by

sub

stan

ce, M

exico‐2013:

Mexico

42012

Heroin

44

ARQ

259

Methamph

etam

ine (non

‐spe

cifie

d)25

925

9AR

Q

7Unkno

wn

77

ARQ

270

Total lab

oratories s

pecifie

d by

sub

stan

ce, M

exico‐2012:

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Mexico

22011

Cocaine (non

‐spe

cifie

d)2

ARQ

5He

roin

5AR

Q

61Unkno

wn

61OC2

012

159

Methamph

etam

ine (non

‐spe

cifie

d)15

9OC2

012

227

Total lab

oratories s

pecifie

d by

sub

stan

ce, M

exico‐2011:

United States of A

merica

632014

Amph

etam

ine (non

‐spe

cifie

d)60

330

616

1063

ARQ

1Psilocybin

11

1AR

Q

103

Tetroh

ydrocann

abinol

857

1149

2120

110

3AR

Q


82

61

110

ARQ

2Co

caine (non

‐spe

cifie

d)2

11

2AR

Q

1He

roin

11

1AR

Q

5,935

Methamph

etam

ine (non

‐spe

cifie

d)4,985

950

5,935

Govt

6,11

5To

tal lab

oratories specified

by substance, United States of A

merica‐2014:

United States of A

merica

112013

Methcathino

ne4

34

31

00

11AR

Q

63Am

phetam

ine (non

‐spe

cifie

d)47

511

376

40

63AR

Q

1An

abolic steroids

11

ARQ

7Cann

abis oil

70

06

01

07

ARQ

26Ph

encyclidine (PCP

)10

124

00

32

26AR

Q

16MDM

A14

20

63

41

16AR

Q

16Tetroh

ydrocann

abinol

142

08

33

016

ARQ

1Ke

tamine

11

ARQ

1Fentanyl

11

ARQ

8GBL, G

HB6

20

11

18

ARQ

4Psilocybin

40

02

11

4AR

Q


101

05

32

011

ARQ

7,932

Methamph

etam

ine (non

‐spe

cifie

d)6,746

1,186

7,932

Govt

8,09

7To

tal lab

oratories specified


merica‐2013:

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

United States of A

merica

252012

Methcathino

ne17

17

122

325

ARQ

84Am

phetam

ine (non

‐spe

cifie

d)49

1619

3114

31

84AR

Q

7Psilocybin

75

11

7AR

Q

2An

abolic steroids

11

12

ARQ

21Ph

encyclidine (PCP

)7

122

12

421

ARQ

15MDM

A11

44

34

15AR

Q


122

102

14AR

Q

14Tetroh

ydrocann

abinol

131

63

22

14AR

Q

4Cann

abis oil

31

34

ARQ

1He

roin

11

1AR

Q

6GBL, G

HB3

33

6AR

Q

9,126

Methamph

etam

ine (non

‐spe

cifie

d)7,703

1,423

9,126

Govt

9,31

9To

tal lab

oratories specified


merica‐2012:

United States of A

merica

102011

Methcathino

ne7

12

61

10AR

Q

57Am

phetam

ine (non

‐spe

cifie

d)45

66

2812

41

57AR

Q

1LSD

11

1AR

Q

5Tetroh

ydrocann

abinol

22

11

15

ARQ

1Co

caine (non

‐spe

cifie

d)1

11

ARQ

5Psilocybin

53

11

5AR

Q

5MDM

A2

21

11

5AR

Q

1Cann

abis oil

11

1AR

Q


83

41

8AR

Q

8GBL, G

HB5

31

48

ARQ

31Ph

encyclidine (PCP

)7

213

13

331

ARQ

9,166

Methamph

etam

ine (non

‐spe

cifie

d)7,915

1,251

9,166

Govt

9,29

8To

tal lab

oratories specified


merica‐2011:

South Am

erica

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Argentina

32014

Synthe

tic drugs

33

ARQ

4Marijuana (herb)

44

Cocaine (non

‐spe

cifie

d)0

ARQ

8Co

caine (non

‐spe

cifie

d)8

8AR

Q

15To

tal lab

oratories specified

by substance, Argen

tina‐20

14:

Argentina

292013

Cocaine (non

‐spe

cifie

d)29

ARQ

29To

tal lab

oratories specified

by substance, Argen

tina‐20

13:

Argentina

312012

Cocaine (non

‐spe

cifie

d)31

ARQ

31To

tal lab

oratories specified

by substance, Argen

tina‐20

12:

Argentina

242011

Cocaine (non

‐spe

cifie

d)24

ARQ

24To

tal lab

oratories specified

by substance, Argen

tina‐20

11:

Bolivia (P

lurin

ational State of)

742014

Cocaine Hy

drochloride

74AR

Q

5,306

Coca base

5,306

ARQ

5,38

0al labo

ratorie

s spe

cifie

d by

sub

stan

ce, B

olivia (P

lurin

ationa

l State of)‐20

14:

Bolivia (P

lurin

ational State of)

372012

Cocaine Hy

drochloride

37AR

Q

4,433

Coca base

4,433

ARQ

4,47

0al labo

ratorie

s spe

cifie

d by

sub

stan

ce, B

olivia (P

lurin

ationa

l State of)‐20

12:

Bolivia (P

lurin

ational State of)

5,252

2011

Cocaine (non

‐spe

cifie

d)5,252

Govt

5,25

2al labo

ratorie

s spe

cifie

d by

sub

stan

ce, B

olivia (P

lurin

ationa

l State of)‐20

11:

Brazil

182014

Cocaine (non

‐spe

cifie

d)0

1818

1818

ARQ

18To

tal lab

oratories s

pecifie

d by

sub

stan

ce, B

razil‐2

014:

Chile

222014

Cocaine (non

‐spe

cifie

d)22

22AR

Q

22To

tal lab

oratories s

pecifie

d by

sub

stan

ce, C

hile‐2014:

Chile

92013

Cocaine (non

‐spe

cifie

d)9

9AR

Q

9To

tal lab

oratories s

pecifie

d by

sub

stan

ce, C

hile‐2013:

Chile

82012

Coca paste

77

8AR

Q

8To

tal lab

oratories s

pecifie

d by

sub

stan

ce, C

hile‐2012:

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Colombia

2,177

2014

Coca paste

2,177

2,177

ARQ

163

Cocaine Hy

drochloride

163

163

ARQ

9Po

tassium permanganate

99

ARQ

1He

roin

11

ARQ

1Ecstasy (non

‐spe

cifie

d)1

1AR

Q

2,35

1To

tal lab

oratories specified

by substance, Colom

bia‐2014:

Colombia

2,131

2013

Coca paste

2,131

2,131

ARQ

3Po


33

ARQ

Heroin

13

ARQ

208

Cocaine Hy

drochloride

208

208

ARQ

1He

roin

1OC2

015

2,34

3To

tal lab

oratories specified

by substance, Colom

bia‐2013:

Colombia

12012

Heroin

11

ARQ

246

Cocaine Hy

drochloride

246

246

ARQ

8Po


88

ARQ

2,110

Coca paste

2,110

2,110

ARQ

2,36

5To

tal lab

oratories specified

by substance, Colom

bia‐2012:

Colombia

201

2011

Cocaine (non

‐spe

cifie

d)20

120

120

1AR

Q

2,200

Coca base

2,200

2,200

2,200

ARQ

1He

roin

11

1AR

Q

7Po


77

7AR

Q

2,40

9To

tal lab

oratories specified

by substance, Colom

bia‐2011:

Ecuado

r2

2013

Cocaine (non

‐spe

cifie

d)2

ARQ

2To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Ecuad

or‐2013:

Ecuado

r4

2012

Cocaine (non

‐spe

cifie

d)4

ARQ

4To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Ecuad

or‐2012:

Ecuado

r5

2011

Cocaine (non

‐spe

cifie

d)5

5AR

Q

5To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Ecuad

or‐2011:

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Peru

272014

Cocaine Hy

drochloride

27AR

Q

598

Coca base

598

ARQ

625

Total lab

oratories specified

by substance, Peru‐2014:

Peru

262012

Cocaine Hy

drochloride

26Govt

1,146

Coca paste

1,146

Govt

1,17

2To

tal lab

oratories specified


Peru

192011

Cocaine Hy

drochloride

1919

19AR

Q

1,498

Coca paste

1,498

1,498

1,498

ARQ

1,51

7To

tal lab

oratories specified


Vene

zuela (Bolivarian Re

public of)

242012

Cocaine (non

‐spe

cifie

d)24

24AR

Q

24bo

ratorie

s specified

by substance, Ven

ezue

la (B

olivarian Re

public of)‐20

12:

Vene

zuela (Bolivarian Re

public of)

172011

Cocaine Hy

drochloride

1717

17AR

Q

17bo

ratorie

s specified

by substance, Ven

ezue

la (B

olivarian Re

public of)‐20

11:

Asia

East and

Sou

th‐East A

sia

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

Cambo

dia

52012

Methamph

etam

ine (non

‐spe

cifie

d)5

SMAR

T

1Ecstasy (non

‐spe

cifie

d),

Methamph

etam

ine (non

‐spe

cifie

d)1

SMAR

T

6To

tal lab

oratories specified

by substance, Cam

bodia‐2012

:

Cambo

dia

22011

Methamph

etam

ine (non

‐spe

cifie

d)2

SMAR

T.

2To

tal lab

oratories specified

by substance, Cam

bodia‐2011

:

China

862014

Non

‐spe

cifie

d86

OC2

016

376

Methamph

etam

ine (non

‐spe

cifie

d)37

6OC2

016

89Ke

tamine

89OC2

016

551

Total lab

oratories s

pecifie

d by

sub

stan

ce, C

hina

‐201

4:

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

China

118

2013

Ketamine

118

ARQ

397

Methamph

etam

ine (non

‐spe

cifie

d)39

7OC2

015

515

Total lab

oratories s

pecifie

d by

sub

stan

ce, C

hina

‐201

3:

China

812012

Ketamine

81SM

ART

17Unkno

wn

17SM

ART

228

Methamph

etam

ine (non

‐spe

cifie

d)22

8SM

ART

326

Total lab

oratories s

pecifie

d by

sub

stan

ce, C

hina

‐201

2:

Hong

Kon

g SA

R, China

112014

Crack

1111

11AR

Q

11To

tal lab

oratories s

pecifie

d by

sub

stan

ce, H

ong Ko

ng SAR

, China

‐201

4:

Hong

Kon

g SA

R, China

62013

Crack

66

6AR

Q

0Methamph

etam

ine (non

‐spe

cifie

d)6

SMAR

T.

6To

tal lab

oratories s

pecifie

d by

sub

stan

ce, H

ong Ko

ng SAR

, China

‐201

3:

Hong

Kon

g SA

R, China

12012

Methamph

etam

ine (non

‐spe

cifie

d)1

11

ARQ

8Crack

88

8AR

Q

1Ke

tamine

11

1AR

Q

10To

tal lab

oratories s

pecifie

d by

sub

stan

ce, H

ong Ko

ng SAR

, China

‐201

2:

Hong

Kon

g SA

R, China

02011

Methamph

etam

ine (non

‐spe

cifie

d)1

SMAR

T.

0To

tal lab

oratories s

pecifie

d by

sub

stan

ce, H

ong Ko

ng SAR

, China

‐201

1:

Indo

nesia

42014

MDM

A4

4AR

Q

3Methamph

etam

ine (non

‐spe

cifie

d)3

3AR

Q

7To

tal lab

oratories specified

by substance, In

done

sia‐2014:

Indo

nesia

22013

Methamph

etam

ine (non

‐spe

cifie

d)2

SMAR

T.

0Ecstasy (non

‐spe

cifie

d)2

SMAR

T.

2To

tal lab

oratories specified

by substance, In

done

sia‐2013:

Indo

nesia

42012

Methamph

etam

ine (non

‐spe

cifie

d)4

1Ecstasy (non

‐spe

cifie

d)3

ARQ

2Ecstasy (non

‐spe

cifie

d)2

2AR

Q

1Precursors (n

on‐spe

cifie

d)1

11

ARQ

7To

tal lab

oratories specified

by substance, In

done

sia‐2012:

of 2

4

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Indo

nesia

22011

Controlled Med

icines

22

ARQ

5Ecstasy (non

‐spe

cifie

d)6

2Unkno

wn

3AR

Q

14Methamph

etam

ine (non

‐spe

cifie

d)13

2Unkno

wn

12AR

Q

21To

tal lab

oratories specified

by substance, In

done

sia‐2011:

Malaysia

112014

Methamph

etam

ine (non

‐spe

cifie

d)11

92

1Methamph

etam

ine (non

‐spe

cifie

d)10

ARQ

6MDM

A6

66

ARQ

8He

roin

88

8AR

Q

25To

tal lab

oratories specified

by substance, M

alaysia‐20

14:

Malaysia

182013

Methamph

etam

ine (non

‐spe

cifie

d)18

SMAR

T.

8Ecstasy (non

‐spe

cifie

d)8

SMAR

T.

26To

tal lab

oratories specified

by substance, M

alaysia‐20

13:

Malaysia

212012

Amph

etam

ine (non

‐spe

cifie

d)21

SMAR

T

6Ecstasy (non

‐spe

cifie

d)6

SMAR

T

21Methamph

etam

ine (non

‐spe

cifie

d)21

SMAR

T.

48To

tal lab

oratories specified

by substance, M

alaysia‐20

12:

Malaysia

12011

Nim

etazep

am1

ARQ

6Ecstasy (non

‐spe

cifie

d)2

Heroin, M

ethamph

etam

ine (non

‐spe

cifie

d)4

ARQ

7He

roin

2Ecstasy (non

‐spe

cifie

d), M

ethamph

etam

ine

(non

‐spe

cifie

d)5

ARQ

13Methamph

etam

ine (non

‐spe

cifie

d)3

Ecstasy (non

‐spe

cifie

d), H

eroin

10AR

Q

27To

tal lab

oratories specified

by substance, M

alaysia‐20

11:

Myanm

ar2

2014

Methamph

etam

ine (non

‐spe

cifie

d)2

DAINAP

2To

tal lab

oratories specified

by substance, M

yanm

ar‐2014:

Myanm

ar2

2013

Methamph

etam

ine (non

‐spe

cifie

d)2

SMAR

T.

2To

tal lab

oratories specified

by substance, M

yanm

ar‐2013:

Myanm

ar1

2012

Amph

etam

ine (non

‐spe

cifie

d)1

11

1AR

Q

4Methamph

etam

ine (non

‐spe

cifie

d)1

34

SMAR

T

5To

tal lab

oratories specified

by substance, M

yanm

ar‐2012:

Myanm

ar2

2011

Methamph

etam

ine (non

‐spe

cifie

d)2

SMAR

T.

2To

tal lab

oratories specified

by substance, M

yanm

ar‐2011:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Philipp

ines

22014

Methamph

etam

ine hydrochloride

2AR

Q

2To

tal lab

oratories specified

by substance, Philip

pine

s‐2014

:

Philipp

ines

12013

Methamph

etam

ine hydrochloride

1AR

Q

1To

tal lab

oratories specified


pine

s‐2013

:

Philipp

ines

72012

Methamph

etam

ine hydrochloride

7FU

7To

tal lab

oratories specified


pine

s‐2012

:

Philipp

ines

62011

Methamph

etam

ine hydrochloride

6AR

Q

6To

tal lab

oratories specified


pine

s‐2011

:

Repu

blic of K

orea

22013

Methamph

etam

ine (non

‐spe

cifie

d)2

20

2AR

Q

2Methamph

etam

ine (non

‐spe

cifie

d)2

SMAR

T.

4To

tal lab

oratories s

pecifie

d by

sub

stan

ce, R

epub

lic of K

orea

‐2013:

Repu

blic of K

orea

12012

Methamph

etam

ine (non

‐spe

cifie

d)1

1AR

Q

2GHB

22

ARQ

3To

tal lab

oratories s

pecifie

d by

sub

stan

ce, R

epub

lic of K

orea

‐2012:

Thailand

12013

Ecstasy (non

‐spe

cifie

d)1

SMAR

T.

5Methamph

etam

ine (non

‐spe

cifie

d)5

SMAR

T.

6To

tal lab

oratories specified

by substance, Tha

iland

‐201

3:

Thailand

62012

Methamph

etam

ine (non

‐spe

cifie

d)6

SMAR

T

6To

tal lab

oratories specified

by substance, Tha

iland

‐201

2:

Thailand

42011

Methamph

etam

ine (non

‐spe

cifie

d)4

SMAR

T.

4To

tal lab

oratories specified

by substance, Tha

iland

‐201

1:

Viet Nam

32013

Ecstasy (non

‐spe

cifie

d)3

SMAR

T.

3To

tal lab

oratories s

pecifie

d by

sub

stan

ce, V

iet N

am‐2013:

Near a

nd M

iddle East /South‐West A

sia

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Afghanistan

742012

Non

‐spe

cifie

d74

Govt

74To

tal lab

oratories specified

by substance, Afgha

nistan

‐201

2:

Afghanistan

422011

Non

‐spe

cifie

d42

Govt

42To

tal lab

oratories specified

by substance, Afgha

nistan

‐201

1:

Iran (Islamic Rep

ublic of)

340

2014

Methamph

etam

ine (non

‐spe

cifie

d)34

0AR

Q

340

Total lab

oratories s

pecifie

d by

sub

stan

ce, Iran (Islamic Rep

ublic of)‐2014:

Iran (Islamic Rep

ublic of)

445

2013

Methamph

etam

ine (non

‐spe

cifie

d)Unkno

wn

445

ARQ

445

Total lab

oratories s

pecifie

d by

sub

stan


ublic of)‐2013:

Iran (Islamic Rep

ublic of)

214

2012

Methamph

etam

ine (non

‐spe

cifie

d)21

4AR

Q

214

Total lab

oratories s

pecifie

d by

sub

stan


ublic of)‐2012:

Lebano

n1

2012

Captagon

13

1Am

phetam

ine base

1AR

Q

1To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Leb

anon

‐2012:

Lebano

n2

2011

Captagon

32

2AR

Q

3Am

phetam

ine base

33

ARQ

5To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Leb

anon

‐2011:

South Asia

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

India

42014

Methamph

etam

ine (non

‐spe

cifie

d)4

13

ARQ

4To

tal lab

oratories specified

by substance, In

dia‐2014:

India

12012

Ketamine

11

11

10

ARQ

3He

roin

2Morph

ine

1AR

Q

4To

tal lab

oratories specified

by substance, In

dia‐2012:

India

12011

Ephe

drine

1AR

Q

1Methamph

etam

ine (non

‐spe

cifie

d)1

11

Ketamine

0AR

Q

2To

tal lab

oratories specified

by substance, In

dia‐2011:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Europe

Eastern Eu

rope

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

Belarus

32013

Amph

etam

ine (non

‐spe

cifie

d)3

ARQ

1Ha

shish

1AR

Q

3Psycho

trop

ic su

bstances

33

33

ARQ

7To

tal lab

oratories specified

by substance, Belarus‐2013:

Belarus

12012

alph

a‐PV

P1

11

ARQ

1Mep

hedron

e1

11

ARQ

1Methamph

etam

ine (non

‐spe

cifie

d)1

11

ARQ

6Am

phetam

ine (non

‐spe

cifie

d)6

66

ARQ

1JW

H‐01

81

11

ARQ

10To

tal lab

oratories specified


Belarus

92011

Amph

etam

ine (non

‐spe

cifie

d)9

99

ARQ

1JW

H‐01

81

11

ARQ

1Methado

ne1

ARQ

11To

tal lab

oratories specified


Russian Fede

ratio

n3

2014

Cann

abis oil, Ha

shish

3AR

Q

35Am

phetam

ine (non

‐spe

cifie

d)1

34AR

Q

13‐Methylfe

ntanyl (3

‐MF, M

efen

tanyl)

1AR

Q

5Marijuana (herb)

5AR

Q

2Methado

ne1

1AR

Q

46To

tal lab

oratories specified

by substance, Russian

Fed

eration‐2014:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Russian Fede

ratio

n4

2013

Cann

abis oil, Ha

shish

4AR

Q

2Methado

ne2

ARQ

3De

somorph

ine

3AR

Q

25Am

phetam

ine (non

‐spe

cifie

d)25

ARQ

1Marijuana (herb)

1AR

Q

1Methamph

etam

ine (non

‐spe

cifie

d)1

ARQ

36To

tal lab

oratories specified


Fed

eration‐2013:

Russian Fede

ratio

n1

2012

Desomorph

ine

1AR

Q

2Methado

ne1

Unkno

wn

1AR

Q

1Cann

abis oil, Ha

shish

10

ARQ

4Marijuana (herb)

4AR

Q

1MDM

A1

ARQ

38Am

phetam

ine (non

‐spe

cifie

d)38

ARQ

2Methamph

etam

ine (non

‐spe

cifie

d)2

ARQ

49To

tal lab

oratories specified


Fed

eration‐2012:

Russian Fede

ratio

n4

2011

Methamph

etam

ine (non

‐spe

cifie

d)4

ARQ

27Am

phetam

ine (non

‐spe

cifie

d)2

25AR

Q

1Marijuana (herb)

10

ARQ

5De

somorph

ine

5AR

Q

37To

tal lab

oratories specified


Fed

eration‐2011:

South‐Eastern Eu

rope

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

DumpsitesBreakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

Bulgaria

122014

Methamph

etam

ine (non

‐spe

cifie

d)12

120

12AR

Q

12To

tal lab

oratories specified

by substance, Bulgaria

‐2014:

Bulgaria

352013

Methamph

etam

ine (non

‐spe

cifie

d)35

3535

ARQ

35To

tal lab

oratories specified


‐2013:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Bulgaria

32012

Amph

etam

ine (non

‐spe

cifie

d)3

33

ARQ

4Methamph

etam

ine (non

‐spe

cifie

d)4

4AR

Q

7To

tal lab

oratories specified


‐2012:

Bulgaria

82011

Amph

etam

ine (non

‐spe

cifie

d)7

18

ARQ

3Methamph

etam

ine (non

‐spe

cifie

d)3

ARQ

11To

tal lab

oratories specified


‐2011:

Romania

12015

3‐MMC, 5 Fluoro AK

B48, 5F‐MDM

B‐PINAC

A, ADB

‐Fub

inaca, bk‐MPA

, MDM

B‐CH

MICA, PB‐22

11

10

OC2

016

15 Fluo

ro AKB

48, A

DB‐Fub

inaca, M

anito

l, MDM

B‐CH

MICA

11

10

OC2

016

1AK

B‐48

f, Ethylphe

nidate, JWH‐018, XLR‐

111

11

0OC2

016

3To

tal lab

oratories specified

by substance, Rom

ania‐2015:

Romania

12013

JWH‐01

81

11

OC2

015

15 Fluo

ro AKB

48, M

ephe

dron

e1

11

OC2

015

1JW

H‐018, M

DPV, UR‐144

11

1OC2

015

1AK

B‐48

f1

11

OC2

015

14‐Methylbup

hedron

e, 4‐

Methylethcathinon

e (4‐M

EC), 5 Fluo

ro

AKB4

8, AKB

‐48f, A

M2201

, JWH 210,

MAM

2201

, UR‐144, UR1

44‐Cycloropir

11

1OC2

015

5To

tal lab

oratories specified

by substance, Rom

ania‐2013:

Turkey

12013

Synthe

tic cannabioids (n

on‐spe

cifie

d)1

11

ARQ

1To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Turkey‐2013

:

Turkey

12012

Methamph

etam

ine (non

‐spe

cifie

d)4

1AR

Q

4Synthe

tic cannabioids (n

on‐spe

cifie

d)4

4AR

Q

2Ecstasy (non

‐spe

cifie

d)2

2AR

Q

7To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Turkey‐2012

:

Turkey

32011

Amph

etam

ine (non

‐spe

cifie

d)3

12

3AR

Q

3To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Turkey‐2011

:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Western & Cen

tral Europ

e

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

Austria

32014

Amph

etam

ine (non

‐spe

cifie

d)3

33

ARQ

9Methamph

etam

ine (non

‐spe

cifie

d)9

81

9AR

Q

12To

tal lab

oratories specified

by substance, Austria‐201

4:

Austria

52013

Methamph

etam

ine (non

‐spe

cifie

d)5

55

ARQ

5To

tal lab

oratories specified


3:

Austria

72012

Methamph

etam

ine (non

‐spe

cifie

d)7

ARQ

7To

tal lab

oratories specified


2:

Austria

22011

Methamph

etam

ine (non

‐spe

cifie

d)2

ARQ

2To

tal lab

oratories specified


1:

Belgium

22014

Unkno

wn

22

2AR

Q

6Am

phetam

ine (non

‐spe

cifie

d)6

64

Precursors (n

on‐spe

cifie

d)2

ARQ

1Unkno

wn

11

1AR

Q

Unkno

wn

221

ARQ

Precursors (n

on‐spe

cifie

d)5

1AR

Q

4GHB

44

4AR

Q

4Precursors (n

on‐spe

cifie

d)4

44

ARQ

17To

tal lab

oratories s

pecifie

d by

sub

stan

ce, B

elgium

‐2014:

Belgium

22013

GHB

22

2AR

Q

4MDM

A3

12

12

2Am

phetam

ine (non

‐spe

cifie

d)2

ARQ

7Am

phetam

ine (non

‐spe

cifie

d)7

17

3Precursors (n

on‐spe

cifie

d)4

ARQ

1Precursors (n

on‐spe

cifie

d)1

1AR

Q


11

1AR

Q

1Non

‐spe

cifie

d1

11

0AR

Q

Unkno

wn

140

ARQ

16To

tal lab

oratories s

pecifie

d by

sub

stan

ce, B

elgium

‐2013:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Belgium

12012

Amph

etam

ine (non

‐spe

cifie

d)1

1AR

Q

1Ecstasy (non

‐spe

cifie

d)1

11

ARQ

1MDM

A1

11

0AR

Q

1GHB

11

1AR

Q

2Unkno

wn

21

2AR

Q

1Legal highs

11

1AR

Q

7To

tal lab

oratories s

pecifie

d by

sub

stan

ce, B

elgium

‐2012:

Belgium

12011

Methamph

etam

ine (non

‐spe

cifie

d)1

11

ARQ

1Am

phetam

ine (non

‐spe

cifie

d)1

11

ARQ

1Ecstasy (non

‐spe

cifie

d)1

11

ARQ

3To

tal lab

oratories s

pecifie

d by

sub

stan

ce, B

elgium

‐2011:

Czech Re

public

272

2014

Methamph

etam

ine (non

‐spe

cifie

d)27

227

2AR

Q

1He

roin

11

ARQ

2Co

deine

22

ARQ

275

Total lab

oratories s

pecifie

d by

sub

stan

ce, C

zech Rep

ublic‐201

4:

Czech Re

public

261

2013

Methamph

etam

ine (non

‐spe

cifie

d)26

126

1AR

Q

261

Total lab

oratories s

pecifie

d by

sub

stan

ce, C

zech Rep

ublic‐201

3:

Czech Re

public

235

2012

Methamph

etam

ine (non

‐spe

cifie

d)23

523

5AR

Q

199

Cann

abis (non

‐spe

cifie

d)19

919

9AR

Q

434

Total lab

oratories s

pecifie

d by

sub

stan

ce, C

zech Rep

ublic‐201

2:

Czech Re

public

32011

Heroin

3AR

Q

338

Methamph

etam

ine (non

‐spe

cifie

d)33

8AR

Q

165

Cann

abis (non

‐spe

cifie

d)56

4338

2816

5AR

Q

506

Total lab

oratories s

pecifie

d by

sub

stan

ce, C

zech Rep

ublic‐201

1:

Estonia

12013

Amph

etam

ine (non

‐spe

cifie

d)1

11

11

ARQ

1To

tal lab

oratories specified

by substance, Eston

ia‐2013:

Estonia

12012

Amph

etam

ine (non

‐spe

cifie

d)1

13

21

1AR

Q

3GHB

34

43

3AR

Q

4To

tal lab

oratories specified

by substance, Eston

ia‐2012:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Estonia

12011

GHB

11

1AR

Q

2Am

phetam

ine (non

‐spe

cifie

d)2

22

ARQ

3To

tal lab

oratories specified

by substance, Eston

ia‐2011:

France

22013

Synthe

tic drugs

12

20

ARQ

2To

tal lab

oratories s

pecifie

d by

sub

stan

ce, France‐2013

:

France

12011

Ecstasy (non

‐spe

cifie

d)1

11

Unkno

wn

0AR

Q

1To

tal lab

oratories s

pecifie

d by

sub

stan

ce, France‐2011

:

Germany

12014

Dimethyltryptamine (DMT)

11

1AR

Q

1GHB

11

1AR

Q

11Am

phetam

ine (non

‐spe

cifie

d)11

92

11AR

Q

3Methamph

etam

ine (non

‐spe

cifie

d)3

33

ARQ

16To

tal lab

oratories specified

by substance, German

y‐2014:

Germany

92013

Methamph

etam

ine (non

‐spe

cifie

d)8

18

9AR

Q

11Am

phetam

ine (non

‐spe

cifie

d)10

19

111

ARQ

20To

tal lab

oratories specified


y‐2013:

Germany

12012

GHB

11

1AR

Q

9Am

phetam

ine (non

‐spe

cifie

d)9

81

9AR

Q

13Methamph

etam

ine (non

‐spe

cifie

d)12

112

13AR

Q

1MDA

11

1AR

Q

24To

tal lab

oratories specified


y‐2012:

Germany

102011

Methamph

etam

ine (non

‐spe

cifie

d)10

1010

ARQ

8Am

phetam

ine (non

‐spe

cifie

d)8

71

8AR

Q

1GHB

11

1AR

Q

19To

tal lab

oratories specified


y‐2011:

Greece

22014

Cocaine (non

‐spe

cifie

d)2

2AR

Q

44Cann

abis (non

‐spe

cifie

d)44

44AR

Q

3He

roin

33

ARQ

3He

roin

3Co

caine (non

‐spe

cifie

d)3

ARQ

52To

tal lab

oratories specified

by substance, Greece‐2014:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Greece

222013

Cann

abis (non

‐spe

cifie

d)22

22AR

Q

Heroin

Cocaine (non

‐spe

cifie

d)22

ARQ

5Co

caine (non

‐spe

cifie

d)5

5AR

Q

4He

roin

44

ARQ

31To

tal lab

oratories specified


Greece

12012

Heroin

1Co

caine (non

‐spe

cifie

d)0

ARQ

7He

roin

7Ca

nnabis (non

‐spe

cifie

d)0

ARQ

25Cann

abis (non

‐spe

cifie

d)25

ARQ

6He

roin

66

ARQ

2Co

caine (non

‐spe

cifie

d)2

2AR

Q

41To

tal lab

oratories specified


Greece

42011

Marijuana (herb)

42

Heroin

2AR

Q

6He

roin

66

ARQ

3Co

caine (non

‐spe

cifie

d)3

3AR

Q

4He

roin

44

Cocaine (non

‐spe

cifie

d)0

ARQ

2He

roin

22

Cann

abis (non

‐spe

cifie

d)0

ARQ

16Cann

abis (non

‐spe

cifie

d)16

1616

ARQ

35To

tal lab

oratories specified


Hungary

12014

Amph

etam

ine (non

‐spe

cifie

d)1

11

ARQ

1To

tal lab

oratories specified

by substance, Hun

gary‐2014:

Hungary

12013

Amph

etam

ine (non

‐spe

cifie

d)1

10

1AR

Q

2Opium

2AR

Q

3To

tal lab

oratories specified

by substance, Hun

gary‐2013:

Hungary

22012

Opium

22

ARQ

1Am

phetam

ine (non

‐spe

cifie

d)1

1AR

Q

3To

tal lab

oratories specified

by substance, Hun

gary‐2012:

Hungary

32011

Acetylated

opium

33

ARQ

2Am

phetam

ine (non

‐spe

cifie

d)2

11

12

ARQ

5To

tal lab

oratories specified

by substance, Hun

gary‐2011:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Latvia

12012

GHB

11

1FU

1To

tal lab

oratories specified

by substance, Latvia‐20

12:

Latvia

22011

Methado

ne2

ARQ

2To

tal lab

oratories specified

by substance, Latvia‐20

11:

Lithuania

22013

Methamph

etam

ine (non

‐spe

cifie

d)2

22

ARQ

2To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Lith

uania‐20

13:

Lithuania

12012

Methamph

etam

ine (non

‐spe

cifie

d)1

11

ARQ

2Am

phetam

ine (non

‐spe

cifie

d)2

22

ARQ

3To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Lith

uania‐20

12:

Nethe

rland

s31

2014

Synthe

tic drugs

31AR

Q

18Precursors (n

on‐spe

cifie

d)18

ARQ

2Psycho

trop

ic su

bstances

2AR

Q

51To

tal lab

oratories s

pecifie

d by

sub

stan

ce, N

ethe

rland

s‐2014

:

Nethe

rland

s11

32011

Synthe

tic drugs

3521

5711

3AR

Q

113

Total lab

oratories s

pecifie

d by

sub

stan

ce, N

ethe

rland

s‐2011

:

Poland

192013

Amph

etam

ine (non

‐spe

cifie

d)1

18AR

Q

19To

tal lab

oratories specified

by substance, Polan

d‐2013:

Poland

12012

Mep

hedron

e1

11

ARQ

9Am

phetam

ine (non

‐spe

cifie

d)7

22

59

ARQ

1Methamph

etam

ine (non

‐spe

cifie

d)1

11

ARQ

1Co

caine (non

‐spe

cifie

d)1

11

ARQ

1Be

nzylmethylketon

e1

11

ARQ

13To

tal lab

oratories specified

by substance, Polan

d‐2012:

Poland

92011

Amph

etam

ine (non

‐spe

cifie

d)9

99

ARQ

2Methamph

etam

ine (non

‐spe

cifie

d)2

22

ARQ

2Mep

hedron

e2

22

ARQ

13To

tal lab

oratories specified

by substance, Polan

d‐2011:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Slovakia

12013

Pented

rone

11

1AR

Q

7Methamph

etam

ine (non

‐spe

cifie

d)7

52

7AR

Q

8To

tal lab

oratories specified

by substance, Slovakia‐20

13:

Slovakia

12012

Methcathino

ne1

11

ARQ

1Pented

rone

11

1AR

Q

7Methamph

etam

ine (non

‐spe

cifie

d)7

52

7AR

Q

9To

tal lab

oratories specified


12:

Slovakia

12011

Fentanyl

11

11

1AR

Q

Methamph

etam

ine (non

‐spe

cifie

d)1

ARQ

1To

tal lab

oratories specified


11:

Spain

32014

Synthe

tic drugs

33

3AR

Q

1He

roin

11

1AR

Q

2Co

caine (non

‐spe

cifie

d)2

22

ARQ

6To

tal lab

oratories specified

by substance, Spa

in‐201

4:

Spain

22013

Cocaine (non

‐spe

cifie

d)2

20

Unkno

wn

2AR

Q

2Am

phetam

ine (non

‐spe

cifie

d)2

12

1AT

S (excluding

Ecstasy)

1AR

Q

1He

roin

11

Heroin

1AR

Q

5To

tal lab

oratories specified

by substance, Spa

in‐201

3:

Spain

12012

Amph

etam

ine (non

‐spe

cifie

d)1

1AR

Q

1He

roin

11

ARQ

3Co

caine (non

‐spe

cifie

d)3

3AR

Q

5To

tal lab

oratories specified

by substance, Spa

in‐201

2:

Spain

32011

Cocaine Hy

drochloride

3AR

Q

3To

tal lab

oratories specified

by substance, Spa

in‐201

1:

Swed

en2014

Amph

etam

ine (non

‐spe

cifie

d)1

13

ARQ

Cocaine (non

‐spe

cifie

d)2

23

ARQ

Non

‐spe

cifie

d1

13

ARQ

Total lab

oratories specified

by substance, Swed

en‐2014:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Switzerland

32013

Methamph

etam

ine (non

‐spe

cifie

d)3

33

ARQ

3To

tal lab

oratories s

pecifie

d by

sub

stan

ce, Switzerland

‐2013:

Ocean

ia

Ocean

ia

Coun

try or Territory

Year

Main substances


Synthesis

Processing

Storage

Dumpsites

Breakdow

n by

pha

seBreakd

own by

scale

Kitchen

Other small-scale

Medium-to-large

Industrial


substances

Additio

nal sub

stances


Breakd


ition

al sub

stan

ces

Source

1

2

3

4

5

7

6

8

Australia

241

2014

Non

‐spe

cifie

d24

1AR

Q

1An

abolic steroids

1AR

Q


1AR

Q

2Synthe

tic cannabioids (n

on‐spe

cifie

d)2

ARQ

10GBL

10AR

Q

7MDA

7AR

Q

2He

roin hom

ebake

2AR

Q

159

Amph

etam

ine (non

‐spe

cifie

d)GHB

159

ARQ

423

Total lab

oratories specified

by substance, Australia‐201

4:

Australia

12013

Heroin hom

ebake

Methylamph

etam

ine

1AR

Q

5Ph

encyclidine (PCP

)5

ARQ

3GHB

Methylamph

etam

ine

3AR

Q

4Pseu

doep

hedrine

4AR

Q

5Cann

abis oil

5Methylamph

etam

ine

0AR

Q

2He

roin hom

ebake

2AR

Q

270

Methylamph

etam

ine

270

ARQ

11Methamph

etam

ine (non

‐spe

cifie

d)10

111

11AR

Q

3GHB

3AR

Q

304

Total lab

oratories specified


3:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Australia

22012

MDM

A1

11

12

ARQ

332

ATS (excluding

Ecstasy)

1150

189

124

553

2113

332

ARQ

4Pseu

doep

hedrine

44

4AR

Q

12C

‐B1

ARQ

339

Total lab

oratories specified


2:

Australia

42011

Heroin hom

ebake

4Govt

3Cann

abis oil

3Govt

16MDM

A16

SMAR

T

556

ATS (excluding

Ecstasy)

556

SMAR

T

579

Total lab

oratories specified


1:

New

Zealand

552014

Methamph

etam

ine (non

‐spe

cifie

d)13

042

055

055

ARQ

26Unkno

wn

2121

26AR

Q

81To

tal lab

oratories specified

by substance, New

Zealand

‐2014:

New

Zealand

22013

MDM

A2

11

ARQ

21Unkno

wn

210

2121

ARQ

1GBL

11

10

11

Mescaline

0AR

Q

53Methamph

etam

ine (non

‐spe

cifie

d)53

5353

047

60

53AR

Q

77To

tal lab

oratories specified

by substance, New

Zealand

‐2013:

New

Zealand

22012

Explosives

11

21

Party Pills

1AR

Q

2Party Pills

22

1Explosives

1AR

Q

84Methamph

etam

ine (non

‐spe

cifie

d)20

2064

483

184

ARQ

2GBL

11

21

12

ARQ

1Ecstasy (non

‐spe

cifie

d)1

11

11

ARQ

3He

roin

33

33

ARQ

94To

tal lab

oratories specified

by substance, New

Zealand

‐2012:

New

Zealand

109

2011

Methamph

etam

ine (non

‐spe

cifie

d)20

3GBL, M

DMA

106

ARQ

109

Total lab

oratories specified

by substance, New

Zealand

‐2011:

of 24

Num

ber o

f cland

estin

e labo

ratorie

s* detected, 201

1‐20

13.

Sources: M

eetin

g of Heads of N

ational D

rug Law Enforcemen

t Agencies, Africa (HONLAF); A

nnual Rep

orts Que

stionn

aire (A

RQ); Official Com

mun

ication on

WDR

‐2012 (OC2

012); G

overnm

ent (Govt); O

fficial Com

mun

ication on

WDR

‐2015

(OC2

015); U

NODC

SMAR

T Programme (SMAR

T); (SMAR

T.); Official Com

mun

ication on

WDR

‐2016 (OC2

016); D

rug Ab

use Inform

ation Network for A

sia and

the Pacific (D

AINAP

)

1. At “synthe

sis labo

ratorie

s” (also

kno

wn as “po

wde

r laboratories”), synthe

tic drugs, drug interm

ediates a

nd precursor che

micals in any form

are m

anufactured from

precursor and

other che

micals. Such labo

ratorie

s may or m

ay not be op

erational at the

time of disc

overy.

2. Laboratories d

edicated

to re

fining, ta

bleting, cuttin

g and packaging are whe

re drugs are processed

but whe

re no eviden

ce of synthesis exists. M

DMA po

wde

r is p

ressed

into ta

blets, pow

der o

r liquid methamph

etam

ine is refin

ed into th

e crystal form, drug po

wde

rs are

diluted (“cut”) to increase bulk and maxim

ize profits a

nd m

aterials tempo

rarily disguised for trafficking pu

rposes are re

covered (e.g. for cocaine

con

version). The

re is no eviden

ce of d

rug synthe

sis at the

locatio

n.

3. At site

s whe

re equ

ipmen

t or che

micals a

re stored

there may be some or even all the

com

pone

nts n

eede

d to m

anufacture drugs, but th

ere is no

evide

nce that drug synthe

sis or a

ny other ope

ratio

n is taking

place.

4. Dum

ping

sites a

re locatio

ns whe

re equ

ipmen

t, packaging or che

mical waste from

synthe

sis labo

ratorie

s have be

en disc

arde

d. How

ever, no eviden

ce exists that d

rug synthe

sis is ta

king

place at such locatio

ns.

5. In

“kitche

n labo

ratorie

s” only basic

equ

ipmen

t and

simple proced

ures are used. Typically, tho

se ope

ratin

g in su

ch labo

ratorie

s have a lim

ited or non

‐existen

t kno

wledge of che

mistry and

simply follow instructions. U

sually, the

re are no sig

nificant stores o

f precursors a

nd th

e am

ount of d

rugs or o

ther su

bstances m

anufactured is for p

ersonal use (a

typical m

anufacture cycle fo

r amph

etam

ine‐type

stim

ulants wou

ld yield less th

an 50 gram

s of the

substance).

6. Peo

ple op

erating in other sm

all‐scale labo

ratorie

s have advanced

che

mical kno

wledge. At such labo

ratorie

s, m

ore complex amph

etam

ine‐type

stim

ulants m

ay be manufactured. The

y may be of similar size

to “kitche

n labo

ratorie

s” but freq

uently employ

non

‐improvise

d eq

uipm

ent. They m

ay also

includ

e expe

rimen

tal laboratories. The

amou

nt m

anufactured is typically fo

r personal use or for use by a lim

ited nu

mbe

r of close associates (a typical m

anufacture cycle fo

r amph

etam

ine‐type

stim

ulants wou

ld yield less th

an 500

grams o

f the

7. M

edium‐to‐large‐scale labo

ratorie

s use commercially available standard equ

ipmen

t and

glassware (in

some cases, custom‐m

ade eq

uipm

ent) and

may ope

rate fo

r lon

ger p

eriods of tim

e. The

y are no

t very mob

ile, m

aking it po

ssible to

recover p

recursor che

micals a

nd

equipm

ent in many cases (it is these type

s of laboratories for w

hich produ

ction estim

ates are th

e most viable and reliable). The

amou

nt m

anufactured at su

ch sites is p

rimarily fo

r illicit e

cono

mic gain (a typical m

anufacture cycle fo

r amph

etam

ine‐type

stim

ulants wou

ld yield

betw

een 0.5 k g and

50 kg of the

substance).

8. Indu

stria

l‐scale labo

ratorie

s use oversized

equ

ipment a

nd glassware that is eith

er custom‐m

ade or purchased

from

indu

stria

l processing sources. Such indu

stria

l ope

ratio

ns produ

ce significant amou

nts o

f amph

etam

ine‐type

stim

ulants in

very short p

eriods of tim

e, th

e am

ount being

limite

d on

ly by access to

precursors, re

agen

ts and

con

sumables in ade

quate qu

antities a

nd th

e logistics a

nd m

anpo

wer to

handle large am

ounts o

f drugs or che

micals a

nd process th

em into th

e ne

xt step

(a typical m

anufacture cycle fo

r amph

etam

ine‐type

stim

ulants wou

ld yield 50 kg or m

ore).

* Th

e term

inology and the categorizations used in th

ese data are based

on the relevant que

stion in th

e An

nual Rep

ort Q

uestionn

aire, specifically que

stions 49‐53, Part 4

(Exten

t and

patterns o

f and

tren

ds in drug crop

cultiv

ation and drug

manufacture and

trafficking). In

particular, the

term

“Labo

ratory” is used

in a broad

sense consisten

t with

its u

se in

the AR

Q, and

includ

es, apart from

synthesis

labo

ratorie

s, establishm

ents ded

icated

to various fo

rms o

f processing (such as cuttin

g, ta

bleting), storage and

disp

osal of e

quipmen

t or chemicals

(dum

psite

s). See

footno

tes for detailed explanations

of 24

illicit americas - united nations office on drugs and crime · · 2016-06-15illicit manufacture...

Documents